Search / 8 results found

from
to
  • Updated

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. A judge formally approved a plan Friday, Sept. 17, 2021 to turn OxyContin maker Purdue Pharma into a new company no longer owned by members of the Sackler family and with its profits going to fight the opioid epidemic. A U.S. bankruptcy court judge signed the plan Friday, more than two weeks after giving it preliminary approval. (AP Photo/Toby Talbot, File)

  • Updated

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. A federal bankruptcy judge on Wednesday, Sept. 1, 2021, gave conditional approval to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades. (AP Photo/Toby Talbot, File)

  • Updated

FILE - In this Aug. 9, 2021, file photo, fake pill bottles with messages about OxyContin maker Purdue Pharma are displayed during a protest outside the courthouse where the bankruptcy of the company is taking place in White Plains, N.Y. A federal bankruptcy judge on Wednesday, Sept. 1, gave conditional approval to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades. (AP Photo/Seth Wenig, File)

AP
  • Updated

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Several U.S. senators are questioning the Food and Drug Administration’s work with a consulting firm that helped businesses sell prescription painkillers during the nation's overdose crisis. Democrat Maggie Hassan of New Hampshire and Republican Chuck Grassley of Iowa, among others, have asked the FDA about potential conflicts of interest in its work with McKinsey and Co. The senators sent a letter Monday, Aug. 23, 2021 to the FDA noting that the agency paid McKinsey more than $140 million after hiring it several times starting in 2008. (AP Photo/Toby Talbot, file)